Annual report pursuant to Section 13 and 15(d)

Consolidated Financial Statement Detail (Tables)

v2.4.1.9
Consolidated Financial Statement Detail (Tables)
12 Months Ended
Dec. 31, 2014
Consolidated Financial Statement Detail [Abstract]  
Receivables
Receivables consisted of the following at December 31, 2014 and 2013 (in thousands):

   
December 31,
 
   
2014
   
2013
 
Trade receivables, net
 
$
2,993
   
$
3,731
 
Other receivables
   
316
     
50
 
Total
 
$
3,309
   
$
3,781
 
Property and equipment
Property and equipment consisted of the following at December 31, 2014 and 2013 (in thousands):

   
December 31,
 
   
2014
   
2013
 
Equipment and furniture
 
$
28,638
   
$
28,365
 
Buildings, leasehold and building improvements
   
9,343
     
9,316
 
Construction-in-progress
   
337
     
225
 
Land
   
310
     
310
 
     
38,628
     
38,216
 
Less:  Accumulated depreciation and amortization
   
(33,508
)
   
(31,760
)
Property and equipment, net
 
$
5,120
   
$
6,456
 
Accrued liabilities
Accrued liabilities consisted of the following at December 31, 2014 and 2013 (in thousands):

   
December 31,
 
   
2014
   
2013
 
Incentive compensation
 
$
4,295
   
$
4,386
 
Accrued payroll and other benefits
   
3,061
     
3,009
 
Accrued clinical trial costs
   
1,424
     
878
 
Other
   
1,112
     
1,661
 
Total
 
$
9,892
   
$
9,934